Prophylactic and therapeutic HPV immunization

被引:0
|
作者
Mueller, M. [1 ]
Gissmann, L. [1 ]
机构
[1] Deutsch Krebsforschungszentrum, Immunochem Abt, D-69120 Heidelberg, Germany
来源
HAUTARZT | 2007年 / 58卷 / 06期
关键词
papilloma virus; cervical carcinoma; prophylactic vaccine; therapeutic vaccine; HPV vaccine;
D O I
10.1007/s00105-007-1346-5
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Papilloma viruses (PV) have been known to cause benign and malignant tumors in animals for more than 100 years. It took over 20 years to win general acceptance for their causative role in anogenital carcinomas in humans in particular in cervial carcinoma. Extensive research has led to the development of a prophylactic vaccine which is now commercially available. It remains to be investigated if HPV-specific therapeutic vaccines can be developed.
引用
收藏
页码:483 / +
页数:5
相关论文
共 50 条